Azipro 250 mg Cipla

What Is Azipro 250 mg Cipla? Azipro 250 mg is a macrolide antibiotic formulation manufactured by Cipla, one of the world’s leading pharmaceutical producers. Its active pharmaceutical ingredient, azithromycin, belongs to the azalide subclass of macrolides — a structurally modified group distinguished by a nitrogen atom inserted into the lactone ring. As a well-characterised reference compound, it occupies a prominent position in antimicrobial research and is available alongside a broad range of compounds at uksteroidshops.co.uk, where researchers can source laboratory materials with confidence. Research Applications and Scientific Context Azithromycin’s pharmacological profile has attracted sustained academic interest. Researchers investigate its concentration-dependent tissue distribution, notably its exceptionally high volume of distribution and prolonged tissue half-life relative to plasma half-life. These pharmacokinetic characteristics make Azipro 250 mg Cipla a relevant tool for studying intracellular drug accumulation within phagocytic cells. Additional research directions include bacterial ribosomal binding kinetics, 50S subunit inhibition modelling, and the evaluation of macrolide resistance gene expression in clinical isolates. Scientists examining immunomodulatory mechanisms have also studied azithromycin’s non-antibiotic properties, including its potential role in attenuating inflammatory cytokine cascades in cell-based assays. Researchers working across antimicrobial pharmacology may also find value in reviewing the oral steroids category, which includes additional orally bioavailable pharmaceutical-grade compounds for comparative pharmacokinetic investigation. Technical Specifications Azipro 250 mg Cipla — Product Specifications Parameter Detail Active Ingredient Azithromycin Strength per Unit 250 mg Drug Class Azalide macrolide antibiotic Manufacturer Cipla Ltd CAS Number 83905-01-5 Molecular Formula C₃₈H₇₂N₂O₁₂ Molecular Weight 748.98 g/mol Form Oral tablet Storage Room temperature, dry, protected from light SKU EU14164 Researchers sourcing azithromycin reference material can explore the full Azithromycin range to compare available strengths and formats. Those involved in broader pharmacological programmes may also find the injectable steroids category useful for accessing parenteral reference compounds alongside oral formulations. Compliance and Safety Notice Azipro 250 mg Cipla is supplied strictly for laboratory research and educational purposes. It is not intended for human consumption, self-administration, or therapeutic use outside of a licensed clinical setting. This product is available to adults aged 18 and over only. Purchasers are solely responsible for ensuring compliance with all applicable local laws and regulations governing the acquisition and use of pharmaceutical compounds. Nothing on this page constitutes medical advice or a recommendation to use this compound in any manner. Always consult a qualified healthcare professional for medical guidance.